← Back to Clinical Trials
Recruiting NCT06717490

Magnesium Sulfate and Postoperative Hypercoagulability in Laparoscopic Gynecological Surgeries

Trial Parameters

Condition Magnesium Sulfate
Sponsor Marianna Mavromati
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2024-12
Completion 2025-11
Interventions
Magnesium sulphatePlacebo Drug

Brief Summary

This will be a prospective randomized, double-blind study, aiming at investigating the effects of magnesium sulfate on postoperative hypercoagulability in patients undergoing laparoscopic gynecological surgeries under general anesthesia

Eligibility Criteria

Inclusion Criteria: * ASA I and II patients * Laparoscopic gynecological surgeries * age \>18 years * Patients receiving prophylactic anticoagulant therapy 12 hours before surgery based on the Caprini score * Patients receiving prophylactic anticoagulant therapy 12 hours postoperatively based on the Caprini score. Exclusion Criteria: * ASA ≥ III * age \<18 years * BMI \>40 kg/m² * Pregnancy * Known hematologic disorders * Liver/kidney/cardiovascular disease * Severe anemia (6,5- 7,9 g/dl) * Inability or refusal to provide informed consent

Related Trials